Market research
OVN.AU Oventus Medical Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- 0.0
- Analyst target
- 0.14
- Dividend yield
- 0.0%
- Beta
- 0.67
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU000000OVN3
- Market cap
- 5M
- P/E ratio
- 0.0
- Analyst target
- 0.14
- Dividend yield
- 0.0%
- Beta
- 0.67
About
About Oventus Medical Limited
Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the OVN.AU discussion.
5 years, 6 months ago
Oventus Medical Limited is currently in a long term downtrend where the price is trading 43.3% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 37.3.
Oventus Medical Limited's total revenue rose by 192.0% to $550K since the same quarter in the previous year.
Its net income has increased by 8.7% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 56.1% to $-1M since the same quarter in the previous year.
Based on the above factors, Oventus Medical Limited gets an overall score of 4/5.